Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 102
- Markets & Stocks
SynBiotic Acquires German Wholesaler Weeco as Clever Leaves & OCT Reveal Plans to Delist as Stocks Struggle
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] German cannabis group SynBiotic has capitalised on the recent explosion in medical cannabis patients since the country’s landmark CanG came into effect last month.
- Uncategorized
New York Mayor Leads Effort to Shut Down Illegal Cannabis Sales in City’s Neighborhoods
New York authorities have launched ‘Operation Padlock to Protect’ in a renewed effort to use ‘the full force of the law’ to shut down illegal cannabis shops and block their continued profileration.
- Uncategorized
Amnestie für Cannabis-Verurteilungen in Deutschland
Geschrieben für Business of Cannabis von Prohibition Partners Senior Analyst Alex Khourdaji Laut einer aktuellen Anfrage des ARD-Hauptstadtstudios an alle Bundesländer in Deutschland, wurden mehr als 125 Personen aufgrund der neuen Amnestieregelungen im Zusammenhang mit der teilweisen Cannabislegalisierung in Deutschland aus dem Gefängnis entlassen.
- Policy & Regulation
Speedy Amnesty for Cannabis Convictions in Germany
Written for Business of Cannabis by Prohibition Partners Senior Analyst Alex Khourdaji According to a recent request made by the ARD to all federal states in Germany, over 125 people have been released from prison due to the new amnesty rules associated with the recent partial cannabis legalisation in the country.
- Uncategorized
DEA Administrator Allegedly Absent from Cannabis Rescheduling Decision
Reports from last week suggesting that the US Drug Enforcement Administration (DEA) would support recommendations for cannabis rescheduling were not approved by the organization’s administrator, one source has suggested.
- CBD Market
Progress for UK CBD Industry: FSA Issues First Positive Safety Assessments in Novel Food Process
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation process.
- Uncategorized
Upcoming US Farm Bill Will ‘Promote Hemp Farming’, but Proposals So Far Fail to Address Intoxicating Substances
Both US Democrat and Republicans have put forward their proposals for the reauthorization of the 2024 Farm Bill, which covers the regulation of the countries industrial hemp industry.
- Uncategorized
Anti-Cannabis Group Prepares Legal Challenge to DEA’s Cannabis Rescheduling
Just days after reports suggested that the US Drug Enforcement Administration (DEA) will support recommendations to reschedule cannabis, anti-reform groups have launched a campaign aimed at stopping it in its tracks.
- Sponsored
Unlocking the Potential: UK’s Evolving Landscape of Medical Cannabis Research
Written for Business of Cannabis by Releaf. The UK moved to legalise medical cannabis in 2018, but while the market has grown rapidly over the last five years, seeing the UK become the second largest market in Europe, barriers remain that continue to prevent the industry from reaching its full potential.
- Events
European Cannabis Leaders to Take Center Stage at Business of Cannabis Awards 2024
The inaugural Business of Cannabis Awards are coming next month, set to honor the movers and shakers of the European cannabis industry.
- Uncategorized
Collapse of a Cannabis Giant: MedMen Files for Bankruptcy Amid $411m Debt Woes
US cannabis giant MedMen has collapsed under the weight of its debt, announcing last week that it has declared bankruptcy, and plans to liquidate its assets.
- Markets & Stocks
Cannabis Stocks Fly on Rescheduling News, Kanabo Revenues Jump 48%, & Apollon to Delist Stock
North American cannabis stocks fly on DEA decision On Tuesday (April 30), news broke via a leak to the press that the US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis, a move expected to have a significant impact on the cannabis industry across the globe.
